News Covis finally pulls preterm birth drug Makena from market Following FDA recommendation for withdrawal, Covid finally pulls premature birth drug Makena.
Views & Analysis COVID-19 and premature babies: Locking down to protect their... Everyone is living with a certain degree of COVID-19-related fear and anxiety at the moment – but spare a thought for the parents of premature and sick babies.
Patients Biosimilars & patient access independent of geographies or s... Rebecca Guntern, Sandoz' CCO, discusses the ‘golden decade’ for generics and biosimilars as so many blockbuster drugs come off patent.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
